Macrophages, dendritic cells, and kidney ischemia-reperfusion injury

Seminars in Nephrology

Volumn 30, Issue 3, 2010, Pages 268-277

  Li, Li ^a   Okusa, Mark D ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Antigen presentation; Inflammation; Innate immunity; Leukocyte

Indexed keywords

CYTOKINE; MICRORNA;

ADAPTIVE IMMUNITY; ARTICLE; CELL HETEROGENEITY; CYTOKINE PRODUCTION; DENDRITIC CELL; GENE EXPRESSION REGULATION; HUMAN; IMMUNOCOMPETENT CELL; INFLAMMATION; INNATE IMMUNITY; KIDNEY ISCHEMIA; LEUKOCYTE; MACROPHAGE; MEDIATOR; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; REPERFUSION INJURY; T LYMPHOCYTE ACTIVATION; TISSUE REPAIR;

ANIMALS; DENDRITIC CELLS; HUMANS; KIDNEY; MACROPHAGES; NEPHRITIS; REPERFUSION INJURY;

EID: 77953890977     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semnephrol.2010.03.005     Document Type: Article

References (68)

1. Kaissling B., Le Hir M. Characterization and distribution of interstitial cell types in the renal cortex of rats. Kidney Int 1994, 45:709-720.
2. Ferenbach D., Hughes J. Macrophages and dendritic cells: what is the difference?. Kidney Int 2008, 74:5-7.
3. Kinsey G.R., Li L., Okusa M.D. Inflammation in acute kidney injury. Nephron Exp Nephrol 2008, 109:e102-e107.
4. Li L., Okusa M.D. Blocking the immune response in ischemic acute kidney injury: the role of adenosine 2A agonists. Nat Clin Pract Nephrol 2006, 2:432-444.
5. Mason J., Torhorst J., Welsch J. Role of the medullary perfusion defect in the pathogenesis of ischemic renal failure. Kidney Int 1984, 26:283-293.
6. Brezis M., Rosen S.N., Epstein F.H. The pathophysiological implications of medullary hypoxia. Am J Kidney Dis 1989, 13:253-258.
7. Thadhani R., Pascual M., Bonventre J.V. Acute renal failure. N Engl J Med 1996, 334:1448-1460.
8. Bonventre J.V., Weinberg J.M. Recent advances in the pathophysiology of ischemic acute renal failure. J Am Soc Nephrol 2003, 14:2199-2210.
9. Schrier R.W., Wang W., Poole B., Mitra A. Acute renal failure: definitions, diagnosis, pathogenesis, and therapy. J Clin Invest 2004, 114:5-14.
10. Plotnikov E.Y., Kazachenko A.V., Vyssokikh M.Y., Vasileva A.K., Tcvirkun D.V., Isaev N.K., et al. The role of mitochondria in oxidative and nitrosative stress during ischemia/reperfusion in the rat kidney. Kidney Int 2007, 72:1493-1502.
11. Brooks C., Wei Q., Cho S.G., Dong Z. Regulation of mitochondrial dynamics in acute kidney injury in cell culture and rodent models. J Clin Invest 2009, 119:1275-1285.
12. Arnold P.E., Van Putten V.J., Lumlertgul D., Burke T.J., Schrier R.W. Adenine nucleotide metabolism and mitochondrial Ca2+ transport following renal ischemia. Am J Physiol 1986, 250:F357-F363.
13. Arnold P.E., Lumlertgul D., Burke T.J., Schrier R.W. In vitro versus in vivo mitochondrial calcium loading in ischemic acute renal failure. Am J Physiol 1985, 248:F845-F850.
14. Jo S.K., Bajwa A., Awad A.S., Lynch K.R., Okusa M.D. Sphingosine1phosphate receptors: biology and therapeutic potential in kidney disease. Kidney Int 2008, 73:1220-1230.
15. Zager R.A., Iwata M., Conrad D.S., Burkhart K.M., Igarashi Y. Altered ceramide and sphingosine expression during the induction phase of ischemic acute renal failure. Kidney Int 1997, 52:60-70.
16. Chatterjee P.K., Brown P.A., Cuzzocrea S., Zacharowski K., Stewart K.N., Mota Filipe H., et al. Calpain inhibitor1 reduces renal ischemia/reperfusion injury in the rat. Kidney Int 2001, 59:2073-2083.
17. Zheng J., DevalarajaNarashimha K., Singaravelu K., Padanilam B.J. Poly (ADPribose) polymerase1 gene ablation protects mice from ischemic renal injury. Am J Physiol Renal Physiol 2005, 288:F387-F398.
18. Jang H.R., Rabb H. The innate immune response in ischemic acute kidney injury. Clin Immunol 2009, 130:41-50.
19. Li L., Huang L., Sung S.S., Vergis A.L., Rosin D.L., Rose C.E., et al. The chemokine receptors CCR2 and CX3CR1 mediate monocyte/macrophage trafficking in kidney ischemiareperfusion injury. Kidney Int 2008, 74:1509-1511.
20. Rabb H. The T cell as a bridge between innate and adaptive immune systems: implications for the kidney. Kidney Int 2002, 61:1935-1946.
21. RodriguezIturbe B., Pons H., HerreraAcosta J., Johnson R.J. Role of immunocompetent cells in non-immune renal diseases. Kidney Int 2001, 59:1626-1640.
22. Awad A.S., Rouse M., Huang L., Vergis A.L., Reutershan J., Cathro H.P., et al. Compartmentalization of neutrophils in the kidney and lung following acute ischemic kidney injury. Kidney Int 2009, 75:689-698.
23. Li L., Huang L., Vergis A.L., Ye H., Bajwa A., Narayan V., et al. IL-17 produced by neutrophils regulates interferon gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 2010, 120:331-342.
24. Kinsey G.R., Sharma R., Huang L., Li L., Vergis A.L., Ye H., et al. Regulatory T cells suppress innate immunity in kidney ischemiareperfusion injury. J Am Soc Nephrol 2009, 20:1744-1753.
25. Anders H.J., Banas B., Schlondorff D. Signaling danger: tolllike receptors and their potential roles in kidney disease. J Am Soc Nephrol 2004, 15:854-867.
26. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
27. Matzinger P. The danger model: a renewed sense of self. Science 2002, 296:301-305.
28. Zhang X., Mosser D.M. Macrophage activation by endogenous danger signals. J Pathol 2008, 214:161-178.
29. Han J., Ulevitch R.J. Limiting inflammatory responses during activation of innate immunity. Nat Immunol 2005, 6:1198-1205.
30. Wilson H.M., Walbaum D., Rees A.J. Macrophages and the kidney. Curr Opin Nephrol Hypertens 2004, 13:285-290.
31. Geissmann F., Jung S., Littman D.R. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 2003, 19:71-82.
32. Fogg D.K., Sibon C., Miled C., Jung S., Aucouturier P., Littman D.R., et al. A clonogenic bone marrow progenitor specific for macrophages and dendritic cells. Science 2006, 311:83-87.
33. Gordon S., Taylor P.R. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005, 5:953-964.
34. Auffray C., Fogg D., Garfa M., Elain G., JoinLambert O., Kayal S., et al. Monitoring of blood vessels and tissues by a population of monocytes with patrolling behavior. Science 2007, 317:666-670.
35. Dauer M., Obermaier B., Herten J., Haerle C., Pohl K., Rothenfusser S., et al. Mature dendritic cells derived from human monocytes within 48 hours: a novel strategy for dendritic cell differentiation from blood precursors. J Immunol 2003, 170:4069-4076.
36. Mohamadzadeh M., Berard F., Essert G., Chalouni C., Pulendran B., Davoust J., et al. Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells. J Exp Med 2001, 194:1013-1020.
37. Chomarat P., Dantin C., Bennett L., Banchereau J., Palucka A.K. TNF skews monocyte differentiation from macrophages to dendritic cells. J Immunol 2003, 171:2262-2269.
38. Delneste Y., Charbonnier P., Herbault N., Magistrelli G., Caron G., Bonnefoy J.Y., et al. Interferongamma switches monocyte differentiation from dendritic cells to macrophages. Blood 2003, 101:143-150.
39. Chomarat P., Banchereau J., Davoust J., Palucka A.K. IL6 switches the differentiation of monocytes from dendritic cells to macrophages. Nat Immunol 2000, 1:510-514.
40. Ysebaert D.K., De Greef K.E., Vercauteren S.R., Ghielli M., Verpooten G.A., Eyskens E.J., et al. Identification and kinetics of leukocytes after severe ischaemia/reperfusion renal injury. Nephrol Dial Transplant 2000, 15:1562-1574.
41. Takada M., Nadeau K.C., Shaw G.D., Maruette K.A., Tilney N.L. The cytokine adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. J Clin Invest 1997, 99:2682-2690.
42. Persy V.P., Verhulst A., Ysebaert D.K., De Greef K.E., De Broe M.E. Reduced postischemic macrophage infiltration and interstitial fibrosis in osteopontin knockout mice. Kidney Int 2003, 63:543-553.
43. Day Y.J., Huang L., Ye H., Linden J., Okusa M.D. Renal ischemiareperfusion injury and adenosine 2A receptormediated tissue protection: role of macrophages. Am J Physiol Renal Physiol 2005, 288:F722-F731.
44. Day Y.J., Huang L., McDuffie M.J., Rosin D.L., Ye H., Chen J.F., et al. Renal protection from ischemia mediated by A2A adenosine receptors on bone marrowderived cells. J Clin Invest 2003, 112:883-891.
45. Lemay S., Rabb H., Postler G., Singh A.K. Prominent and sustained upregulation of gp130signaling cytokines and the chemokine MIP2 in murine renal ischemiareperfusion injury. Transplantation 2000, 69:959-963.
46. Takada M., Chandraker A., Nadeau K.C., Sayegh M.H., Tilney N.L. The role of the B7 costimulatory pathway in experimental cold ischemia/reperfusion injury. J Clin Invest 1997, 100:1199-1203.
47. Tacke F., Alvarez D., Kaplan T.J., Jakubzick C., Spanbroek R., Llodra J., et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J Clin Invest 2007, 117:185-194.
48. Oh D.J., Dursun B., He Z., Lu L., Hoke T.S., Ljubanovic D., et al. Fractalkine receptor (CX3CR1) inhibition is protective against ischemic acute renal failure in mice. Am J Physiol Renal Physiol 2008, 294:F264-F271.
49. Furuichi K., Wada T., Iwata Y., Kitagawa K., Kobayashi K., Hashimoto H., et al. CCR2 signaling contributes to ischemiareperfusion injury in kidney. J Am Soc Nephrol 2003, 14:2503-2515.
50. Holdsworth S.R., Neale T.J., Wilson C.B. Abrogation of macrophagedependent injury in experimental glomerulonephritis in the rabbit. Use of an anti-macrophage serum. J Clin Invest 1981, 68:686-698.
51. Holdsworth S.R., Neale T.J. Macrophageinduced glomerular injury. Cell transfer studies in passive autologous antiglomerular basement membrane antibodyinitiated experimental glomerulonephritis. Lab Invest 1984, 51:172-180.
52. Jo S.K., Sung S.A., Cho W.Y., Go K.J., Kim H.K. Macrophages contribute to the initiation of ischaemic acute renal failure in rats. Nephrol Dial Transplant 2006, 21:1231-1239.
53. Buch T., Heppner F.L., Tertilt C., Heinen T.J., Kremer M., Wunderlich F.T., et al. A Creinducible diphtheria toxin receptor mediates cell lineage ablation after toxin administration. Nat Methods 2005, 2:419-426.
54. Li L., Huang L., Sung S.J., Lobo P.I., Brown M.G., Gregg R.K., et al. NKT cell activation mediates neutrophil IFNgamma production and renal ischemiareperfusion injury. J Immunol 2007, 178:589-911.
55. Hayakawa Y., Takeda K., Yagita H., Van Kaer L., Saiki I., Okumura K. Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J Immunol 2001, 166:6012-6018.
56. Melnikov V.Y., Ecder T., Fantuzzi G., Siegmund B., Lucia M.S., Dinarello C.A., et al. Impaired IL18 processing protects caspase1deficient mice from ischemic acute renal failure. J Clin Invest 2001, 107:1145-1152.
57. Mariathasan S., Monack D.M. Inflammasome adaptors and sensors: intracellular regulators of infection and inflammation. Nat Rev Immunol 2007, 7:31-40.
58. Ogura Y., Sutterwala F.S., Flavell R.A. The inflammasome: first line of the immune response to cell stress. Cell 2006, 126:659-662.
59. Nathan C.F., Hibbs J.B. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol 1991, 3:65-70.
60. Nathan C.F. Mechanisms of macrophage antimicrobial activity. Trans R Soc Trop Med Hyg 1983, 77:620-630.
61. Shiloh M.U., MacMicking J.D., Nicholson S., Brause J.E., Potter S., Marino M., et al. Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 1999, 10:29-38.
62. Shipley J.M., Wesselschmidt R.L., Kobayashi D.K., Ley T.J., Shapiro S.D. Metalloelastase is required for macrophagemediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci U S A 1996, 93:3942-3946.
63. Houghton A.M., Hartzell W.O., Robbins C.S., GomisRuth F.X., Shapiro S.D. Macrophage elastase kills bacteria within murine macrophages. Nature 2009, 460:637-641.
64. Saal S., Harvey S.J. MicroRNAs and the kidney: coming of age. Curr Opin Nephrol Hypertens 2009, 18:317-323.
65. Zager R.A., Johnson A.C., Lund S. Uremia impacts renal inflammatory cytokine gene expression in the setting of experimental acute kidney injury. Am J Physiol Renal Physiol 2009, 297:F961-F970.
66. Bi Y., Liu G., Yang R. MicroRNAs: novel regulators during the immune response. J Cell Physiol 2009, 218:467-472.
67. Lu L.F., Liston A. MicroRNA in the immune system, microRNA as an immune system. Immunology 2009, 127:291-298.
68. O'Connell R.M., Taganov K.D., Boldin M.P., Cheng G., Baltimore D. MicroRNA155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 2007, 104:1604-1609.